View Older Stories View More Recent Stories

Sep 24, 2019 05:57AM Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Sep 13, 2019 06:32AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Sep 11, 2019 04:30AM Zealand Pharma completes subscription of new shares and registration of capital increase
Sep 10, 2019 04:30PM Update regarding registration of new shares for Zealand Pharma
Sep 5, 2019 05:30PM Zealand Pharma major shareholder announcement: Van Herk Investments
Sep 5, 2019 06:27AM Zealand Pharma (ZEAL) announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Sep 5, 2019 02:00AM Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Sep 5, 2019 02:00AM Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Sep 3, 2019 05:57AM Zealand Pharma (ZEAL), Boehringer Ingelheim Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Sep 3, 2019 02:00AM Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Aug 30, 2019 10:00AM Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Aug 29, 2019 10:00AM Zealand Pharma to attend Morgan Stanley 17th Annual Global Healthcare Conference
Aug 28, 2019 06:16AM Zealand Pharma (ZEAL) Announces Matthew Dallas as CFO
Aug 28, 2019 05:00AM Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Aug 28, 2019 05:00AM Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Aug 28, 2019 02:00AM Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Aug 28, 2019 02:00AM Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Aug 27, 2019 04:00AM Zealand Pharma relocates headquarters to accommodate growth
Aug 23, 2019 07:02AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Aug 15, 2019 09:00AM Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Aug 15, 2019 09:00AM Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Aug 1, 2019 11:00AM Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019
Aug 1, 2019 11:00AM Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019
Jul 29, 2019 05:00AM Zealand Pharma announces change in corporate management
Jun 28, 2019 10:00AM Total number of shares and voting rights in Zealand Pharma at June 30, 2019
Jun 26, 2019 05:55AM Zealand Pharma (ZEAL) Reports First Patient Dosing in Phase 1 Clinical Trial to Evaluate ZP7570 as Treatment for SBS
Jun 26, 2019 02:00AM Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome
Jun 21, 2019 03:00AM Zealand Pharma introduces new website to support people living with short bowel syndrome
Jun 14, 2019 05:00AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Jun 13, 2019 02:20PM Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
Jun 13, 2019 04:07AM Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program
Jun 11, 2019 06:08AM Zealand Pharma (ZEAL) Highlights Results from Pivotal Phase 3 Study of Sasiglucagon as Treatment for Severe Hypoglycemia
Jun 10, 2019 08:00PM Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
Jun 6, 2019 06:06AM Zealand Pharma (ZEAL), Beta Bionics Report Results from Phase 2 Home-use Clinical Trial Testing iLet Bionic Pancreas Using Dasiglucagion
Jun 6, 2019 02:00AM Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet™ bionic pancreas using dasiglucagion
Jun 4, 2019 10:00AM Zealand Pharma to attend Citi European Healthcare Conference
Jun 3, 2019 11:04AM Total number of shares and voting rights in Zealand Pharma as of May 31, 2019
May 28, 2019 02:10PM Correction: Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
May 28, 2019 06:37AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
May 27, 2019 10:00AM Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences
May 22, 2019 08:00AM Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes
May 16, 2019 09:00AM Zealand Pharma initiates several Phase 3 studies and grows cash position in the first quarter of 2019
May 16, 2019 09:00AM Zealand Pharma initiates several Phase 3 studies and grows cash position in the first quarter of 2019
May 14, 2019 05:40AM Zealand Pharma (ZEAL) Reports Achievement of Primary & All Key Secondary Endpoints in Confirmatory Phase 3 trial with Dasiglucagon
May 14, 2019 04:32AM Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia
May 14, 2019 04:32AM Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia
May 7, 2019 07:29AM Zealand Pharma (ZEAL) Reports First Patient Enrollment in Phase 3 Extension Study of Glepaglutide for Treatment for SBS
May 7, 2019 07:00AM Zealand Pharma enrolls first patient in Phase 3 extension study of glepaglutide for treatment for short bowel syndrome
May 6, 2019 05:00AM Zealand Pharma hosts conference call on May 16 at 4 pm CET (10 am EST) to present first quarter results for 2019
Apr 11, 2019 07:00AM Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar
View More Recent Stories View Older Stories